PRMT1 and hepatocellular carcinoma: Here, we also demonstrated the overexpression of PRMT1 in HCC clinical samples and that the PRMT1 knockdown inhibited growth and spheroid formation in HCC cell lines, implying that PRMT1 inhibitors may be an effective therapeutic method in HCC treatment.